RAPP Sale Disclosure
Ceesay Abraham · SEC Form 4 · Filed Oct 8, 2026
Sale
Calculated transaction value
$35.17K
Ceesay Abraham Chief Executive Officer
RAPP
Rapport Therapeutics
RAPP
Transaction date
Oct 7, 2026
Public filing date
Oct 8, 2026
Filing lag
Filed 1 day later
RAPP daily price context
Close on/before transaction
$30.86
Oct 7, 2026
First close after public filing
$30.65
Oct 9, 2026
Return after filing · so far
0.0%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,147 shares @ $30.66
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-417919
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$143.27K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rapport Therapeutics, Inc. RAPP Current | Sale | Oct 7, 2026 | $35.17K |
| Rapport Therapeutics, Inc. RAPP | Sale | Oct 6, 2026 | $108.11K |